Silent Spring Institute
EPANonrulemakingEPA-HQ-OPPT-2016-0735

HBCD (Hexabromocyclododecane) or Cyclic Aliphatic Bromide Cluster; TSCA Review and Risk Evaluation

RIN
Last modified
May 21, 2026
Comment window
closed 2903d ago
Silent Spring Institute filings
3

Activity

Silent Spring Institute filed 3 comments on this docket between Mar 27, 2017 and Sep 12, 2018. 24 other organizations filed here. The comment window closed 2903d ago.

What Silent Spring Institute filed (3)

Sep 12, 2018· Comment submitted by Jessica Helm, Postdoctoral Research Fellow, Silent Spring Institute· EPA-HQ-OPPT-2016-0735-0099

Filed on regulations.gov — full text not in the inline record.

Sep 26, 2017· Comment submitted by Jessica Helm, PhD and Kathryn Rodgers, MPH, Silent Spring Institute· EPA-HQ-OPPT-2016-0735-0063

Filed on regulations.gov — full text not in the inline record.

Mar 27, 2017· Comment submitted by Ruthann Rudel, Kathryn Rodgers, Silent Spring Institute· EPA-HQ-OPPT-2016-0735-0025

Filed on regulations.gov — full text not in the inline record.

Abstract

The EPA has prioritized chemicals for risk evaluation to address risks of injury to health and the environment, including HBCD (CASRNs 25637-98-4; 3194-55-6; and 3194-57-8). The EPA is requesting any information from the public on HBCD both domestically and internationally.

View on regulations.gov →